DNA Mismatch Repair Protein Immunohistochemistry and MLH1 Promotor Methylation Testing for Practical Molecular Classification and the Prediction of Prognosis in Endometrial Cancer

about

DNA Mismatch Repair Protein Immunohistochemistry and MLH1 Promotor Methylation Testing for Practical Molecular Classification and the Prediction of Prognosis in Endometrial Cancer

Item

http://www.wikidata.org/entity/Q58726243

description

scientific article published on 21 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

DNA Mismatch Repair Protein Im ...... rognosis in Endometrial Cancer

@en

DNA Mismatch Repair Protein Im ...... rognosis in Endometrial Cancer

@nl

type

Item

label

DNA Mismatch Repair Protein Im ...... rognosis in Endometrial Cancer

@en

DNA Mismatch Repair Protein Im ...... rognosis in Endometrial Cancer

@nl

prefLabel

DNA Mismatch Repair Protein Im ...... rognosis in Endometrial Cancer

@en

DNA Mismatch Repair Protein Im ...... rognosis in Endometrial Cancer

@nl

P1476

DNA Mismatch Repair Protein Im ...... rognosis in Endometrial Cancer

@en

P2093

Bang Hyun Lee

http://www.w3.org/2001/XMLSchema#string

Hanbyoul Cho

http://www.w3.org/2001/XMLSchema#string

Jae-Hoon Kim

http://www.w3.org/2001/XMLSchema#string

Jisup Kim

http://www.w3.org/2001/XMLSchema#string

Seong Jin Cho

http://www.w3.org/2001/XMLSchema#string

P2860

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1

Integrated genomic characterization of endometrial carcinoma

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study

Mapping the immunosuppressive environment in uterine tumors: implications for immunotherapy.

Evaluation of clinical criteria for the identification of Lynch syndrome among unselected patients with endometrial cancer.

Evaluating the yield of medical tests.

Two pathogenetic types of endometrial carcinoma.

Prognostic significance of POLE proofreading mutations in endometrial cancer.

P304

279

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/CANCERS10090279

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30134578

http://www.w3.org/2001/XMLSchema#string

P921

cancer research

immunohistochemistry

P932

6162750

http://www.w3.org/2001/XMLSchema#string